Drug prices projected to jump 7.35% for hospitals

Pharmaceutical consulting company Vizient expects drug prices for hospitals to rise 7.35 percent between July 2018 and the same time next year.

The increase is slightly lower than in previous years, reflecting fewer products projected to see “exorbitant” price hikes, according to Vizient’s report.

“While slightly lower, this increase still represents a substantial impact, especially given the use of many high-cost drugs across our members,” Dan Kistner, senior vice president of pharmacy solutions for Vizient, said in a press release.

Find more on the story at HealthExec:

""

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.